期刊文献+

健康体检者脂蛋白磷脂酶A2和髓过氧化物酶的参考范围及其临床意义

Reference Range and Clinical Significance of Lipoprotein Phospholipase A2 and Myeloperoxidase in Healthy Persons
下载PDF
导出
摘要 目的 研究苏州地区健康体检者血清中脂蛋白磷脂酶A2(Lp-PLA2)和髓过氧化物酶(MPO)的浓度水平,探讨健康人群血清中Lp-PLA2和MPO的参考范围及其临床应用价值.方法 选取236 名健康体检者,其中男性123 名,平均年龄(43.7±16.6)岁,女性113 名,平均年龄(42.8±14.0)岁,采用苏州博源医疗科技有限公司生产的试剂进行测定,建立健康体检者血清中Lp-PLA2和MPO的参考范围,并对其临床应用进行分析.结果 男性的Lp-PLA2和MPO平均浓度水平高于女性,但差异无统计学意义(P>0.05);随着年龄的增加,Lp-PLA2和MPO平均浓度水平均呈上升的趋势;健康人群血清中Lp-PLA2的参考范围为<695.3 U/L,MPO的参考范围为<111.0 ng/mL.结论 该研究初步建立了苏州地区健康人血清中Lp-PLA2和MPO的参考范围,为临床上评估健康体检者是否有心血管疾病风险提供了依据. Objective To study the concentrations of lipoprotein phospholipase A2 (Lp-PLA2) and myeloperoxidase (MPO) in serum of healthy people in Suzhou area, and to explore the reference range and clinical application value of serum Lp-PLA2 and MPO. Methods 236 cases of healthy physical examination were selected, including 123 males (mean age (43.7±16.6) years) and 113 females (mean age (42.8±14.0) years). The reference range of Lp-PLA2 and MPO in serum of healthy physical examination patients was established by using reagents produced by Suzhou Boyuan Medical Technology Co., Ltd., and their clinical application was analyzed. Results The average concentration of Lp-PLA2 and MPO in males was higher than that in females, but there was no significant difference. With the increase of age, the average concentration of Lp-PLA2 and MPO increased. The reference range of Lp-PLA2 in serum of healthy people was <695.3 U/L, and the reference range of MPO was <111.0 ng/mL. Conclusion The reference range of Lp-PLA2 and MPO in serum of healthy people in Suzhou area is established, which provides a basis for clinical evaluation of cardiovascular disease risk in healthy people.
作者 徐为高 张剑峰 XU Wei-gao;ZHANG Jian-feng(Clinical Laboratory,Yancheng Maternal and Child Health Hospital,Yancheng,Jiangsu,224002,China;Clinical Laboratory,East District of Suzhou Municipal Hospital,Suzhou,Jiangsu,215001,China)
出处 《中国血液流变学杂志》 CAS 2019年第2期208-211,共4页 Chinese Journal of Hemorheology
关键词 心血管疾病 脂蛋白磷脂酶A2 髓过氧化物酶 参考范围 cardiovascular diseases lipoprotein phospholipase A2 myeloperoxidase reference range
  • 相关文献

参考文献4

二级参考文献78

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2Leoncini M,Toso A,Maioli M,et al.Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study[J].Am Heart J,2014,168(5):792-797.
  • 3Sexton TR,Wallace EL,Macaulay TE,et al.The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome[J].J Thromb Thrombolysis,2014,12(12):1-6.
  • 4Gurumurthy P,Borra SK,Yeruva RK,et al.Estimation of ischemia modified albumin (IMA) levels in patients with acute coronary syndrome[J].Indian J Clin Biochem,2014,29(3):367-371.
  • 5Koch C,Henrich M,Heidt MC.Sequential analysis of myeloperoxidase for prediction of adverse events after suspected acute coronary ischemia[J].Clin Cardiol,2014,17(11):247-254.
  • 6Peter Libby,Paul M Ridker,G?ran K. Hansson.Progress and challenges in translating the biology of atherosclerosis. Nature . 2011
  • 7Virmani R,Kolodgie FD,Burke AP,et al.Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions[].Arteriosclerosis.2000
  • 8GreenlandP, AlpertJS, BellerGA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol, 2010, 56(25):e50–e103.
  • 9JellingerPS, SmithDA, MehtaAE, et al. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis[J].Endocr Pract, 2012, 18Suppl 1:1–78.
  • 10SudhirK. Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease[J].J Clin Endocrinol Metab, 2005, 90(5):3100–3105.

共引文献543

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部